Table 5. CXCR4 expression at the protein and mRNA levels and overall survival in TC, ATC and SCLC.
Immunohistochemistry TC | |||
IRS 0–12 | N = 22 | Events | Median survival [months] |
IRS 0–4 | N=21 | 1 | 86.2 |
IRS 5–12 | N=1 | 0 | 77.2 |
CXCR4-mRNA Quartiles TC | |||
PCR Quartiles 0–3 (ΔCT values) | N=19 | Events | Median survival [months] |
0 (26.00–29.49) | N=1 | 0 | 126.2 |
1 (29.50–32.99) | N=4 | 0 | 90.7 |
2 (33.00–36.49) | N=10 | 0 | 80.7 |
3 (36.50–40.00) | N=4 | 1 | 77.7 |
CXCR4-Immunohistochemistry ATC | |||
IRS 0–12 | N=27 | Events | Median survival [months] |
IRS 0–4 | N=23 | 7 | 96.2 |
IRS 5–12 | N=4 | 1 | 62.1 |
CXCR4-mRNA Quartiles ATC | |||
PCR Quartiles 0–3 (ΔCT values) | N=19 | Events | Median survival [months] |
2 (33.00–36.49) | N=12 | 2 | 100.7 |
3 (36.50–40.00) | N=7 | 2 | 69.2 |
CXCR4-Immunohistochemistry SCLC | |||
IRS 0–12 | N=21 | Events | Median survival [months] |
IRS 0–4 | N=3 | 2 | 90.7 |
IRS 5–12 | N=18 | 16 | 17.9 |
CXCR4-mRNA Quartiles SCLC | |||
PCR Quartiles 0–3 (ΔCT values) | N=18 | Events | Median survival [months] |
2 (33.00–36.49) | N=2 | 2 | 63.0 |
3 (36.50–40.00) | N=16 | 13 | 17.9 |